Evidence map›Paper›PMID 38948694›Full record

ArticlebioRxiv : the preprint server for biology2024

Programmable promoter editing for precise control of transgene expression.

Sneha R Kabaria, Yunbeen Bae, Mary E Ehmann, Adam M Beitz, Brittany A Lende-Dorn, Emma L Peterman, Kasey S Love, Deon S Ploessl, Kate E Galloway

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Sneha R KabariaDepartment of Chemical Engineering, MIT, Cambridge, MA 02139, USA.
Yunbeen BaeDepartment of Chemical Engineering, MIT, Cambridge, MA 02139, USA.
Mary E EhmannDepartment of Chemical Engineering, MIT, Cambridge, MA 02139, USA.
Adam M BeitzDepartment of Chemical Engineering, MIT, Cambridge, MA 02139, USA.
Brittany A Lende-DornDepartment of Chemical Engineering, MIT, Cambridge, MA 02139, USA.
Emma L PetermanDepartment of Chemical Engineering, MIT, Cambridge, MA 02139, USA.ORCID 0000-0001-7402-576X
Kasey S LoveDepartment of Biological Engineering, MIT, Cambridge, MA 02139, USA.ORCID 0000-0001-7544-0340
Deon S PloesslDepartment of Chemical Engineering, MIT, Cambridge, MA 02139, USA.
Kate E GallowayDepartment of Chemical Engineering, MIT, Cambridge, MA 02139, USA.ORCID 0000-0001-7416-3193

Funding

VIRUS PRODUCTION COREP30CA014051 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI Jacqueline A. Lees · 1985 to 2026
$93.9M
Multiscale tools and approaches for understanding and engineering cell-fate transitionsR35GM143033 · NIGMS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI GALLOWAY, KATE ELIZABETH · 2021 to 2025
$1.9M
Mapping p53 dynamics to cell-fate outcomes in reprogramming and oncogenesisF99CA284280 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI BEITZ, ADAM MATTHEW · 2023 to 2024
$98k
NCI NIH HHS F99 CA284280NCI NIH HHS P30 CA014051NIGMS NIH HHS R35 GM143033
6 · The paper itself

Abstract

Subtle changes in gene expression direct cells to distinct cellular states. Identifying and controlling dose-dependent transgenes require tools for precisely titrating expression. To this end, we developed a highly modular, extensible framework called DIAL for building editable promoters that allow for fine-scale, heritable changes in transgene expression. Using DIAL, we increase expression by recombinase-mediated excision of spacers between the binding sites of a synthetic zinc finger transcription factor and the core promoter. By nesting varying numbers and lengths of spacers, DIAL generates a tunable range of unimodal setpoints from a single promoter. Through small-molecule control of transcription factors and recombinases, DIAL supports temporally defined, user-guided control of transgene expression that is extensible to additional transcription factors. Lentiviral delivery of DIAL generates multiple setpoints in primary cells and iPSCs. As promoter editing generates stable states, DIAL setpoints are heritable, facilitating mapping of transgene levels to phenotypes. The DIAL framework opens new opportunities for tailoring transgene expression and improving the predictability and performance of gene circuits across diverse applications.

Identifiers

PMID38948694
PMCPMC11212971

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.